0001177648-19-000003.txt : 20190213 0001177648-19-000003.hdr.sgml : 20190213 20190213205023 ACCESSION NUMBER: 0001177648-19-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190211 FILED AS OF DATE: 20190213 DATE AS OF CHANGE: 20190213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARTER BRUCE L A CENTRAL INDEX KEY: 0001225503 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35839 FILM NUMBER: 19600083 MAIL ADDRESS: STREET 1: C/O ZYMOGENETICS, INC. STREET 2: 1201 EASTLAKE AVENUE CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENANTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001177648 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 500 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617 607 0800 MAIL ADDRESS: STREET 1: 500 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-02-11 0001177648 ENANTA PHARMACEUTICALS INC ENTA 0001225503 CARTER BRUCE L A C/O ENANTA PHARMACEUTICALS, INC. 500 ARSENAL STREET WATERTOWN MA 02472 1 0 0 0 Common Stock 2019-02-11 4 M 0 2734 23.40 A 2734 D Common Stock 2019-02-11 4 S 0 2734 90.0153 D 0 D Common Stock 2019-02-12 4 M 0 5000 23.40 A 5000 D Common Stock 2019-02-12 4 S 0 5000 90.00 D 0 D Stock Option (Right to Buy) 23.40 2019-02-11 4 M 0 2734 0 D 2023-11-22 Common Stock 2734 6546 D Stock Option (Right to Buy) 23.40 2019-02-12 4 M 0 5000 0 D 2023-11-22 Common Stock 5000 1546 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2018. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.045, inclusive. 100% of the shares subject to the option are fully vested and exercisable. /s/ Nathaniel S. Gardiner as attorney-in-fact 2019-02-13